arginyl-glycyl-aspartic acid has been researched along with Cardiac Remodeling, Ventricular in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergner, C; David, R; Döring, P; Gäbel, R; Ince, H; Joksch, M; Krause, BJ; Kurth, J; Lang, CI; Lemcke, H; Lindner, T; Müller, P; Steinhoff, G; Stenzel, J; Vasudevan, P; Vollmar, B; Wester, HJ | 1 |
| Cohen, S; Feinberg, MS; Holbova, R; Landa, N; Leor, J; Ruvinov, E; Tsur-Gang, O | 1 |
| Du, KT; Gu, Y; Lee, RJ; Mihardja, S; Sievers, RE; Yu, J | 1 |
| Blankesteijn, WM; Daemen, MJ; Fujimoto, A; Fujimoto, S; Hofstra, L; Isobe, S; Li, P; Lovhaug, D; Narula, J; Narula, N; Petrov, A; Pitt, B; Reutelingsperger, C; Smits, JF; van den Borne, SW; Vannan, MA; Wong, ND; Zandbergen, HR; Zannad, F | 1 |
| Mann, DL | 1 |
5 other study(ies) available for arginyl-glycyl-aspartic acid and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
[
Topics: Acetates; Animals; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Integrin alphaVbeta3; Magnetic Resonance Imaging; Mice; Myocardial Infarction; Neovascularization, Physiologic; Oligopeptides; Positron-Emission Tomography; Stem Cell Transplantation; Ventricular Remodeling | 2020 |
The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction.
Topics: Actins; Alginates; Animals; Animals, Newborn; Biocompatible Materials; Female; Hydrogels; Immunohistochemistry; Materials Testing; Muscle, Smooth; Myocardial Infarction; Oligopeptides; Peptides; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2009 |
The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model.
Topics: Alginates; Animals; Cell Adhesion; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Female; Glucuronic Acid; Hexuronic Acids; Humans; Myocardial Infarction; Oligopeptides; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carbocyanines; Cardiovascular Agents; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Fibrillar Collagens; Fibroblasts; Fibrosis; Losartan; Mice; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Oligopeptides; Predictive Value of Tests; Spironolactone; Technetium; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Molecular imaging and the failing heart: through the looking glass.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Carbocyanines; Cardiovascular Agents; Drug Therapy, Combination; Echocardiography; Fibrillar Collagens; Fibroblasts; Fibrosis; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Oligopeptides; Predictive Value of Tests; Technetium; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left; Ventricular Remodeling | 2009 |